tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apte, RN; Cohen, S; Dvir, T; Elkabets, M; Sarfati, G | 1 |
| Bos, IS; Dekkers, BG; Halayko, AJ; Meurs, H; Zaagsma, J | 1 |
2 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Disease Models, Animal
| Article | Year |
|---|---|
Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
Topics: Animals; Disease Models, Animal; Drug Delivery Systems; Injections, Intravenous; Laminin; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microfluidics; Nanoparticles; Oligopeptides; Polymers; Rheology; Spectroscopy, Fourier Transform Infrared; Static Electricity; Tissue Distribution | 2011 |
The laminin β1-competing peptide YIGSR induces a hypercontractile, hypoproliferative airway smooth muscle phenotype in an animal model of allergic asthma.
Topics: Administration, Topical; Airway Remodeling; Animals; Asthma; Disease Models, Animal; Guinea Pigs; Humans; Laminin; Lung; Muscle Contraction; Muscle, Smooth; Oligopeptides; Phenotype | 2010 |